Skip to main content
Log in

Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna

Evaluierung von diagnostischen und therapeutischen Ansätzen von Studenten der Medizinischen Universität Wien bei Patienten mit fortgeschrittener Dyspnoe

  • Themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

GRUNDLAGEN: Bei Patienten mit fortgeschrittener Krebserkrankung ist Dyspnoe eines der häufigsten Symptome. Opioide zählen mit zur Standardtherapie. ZIEL: Ziel der Studie war, den Wissenstand von Studenten im 8. Semester über Diagnose und Therapiemaßnahmen von Dyspnoe zu evaluieren. METHODIK: Ein Fallbericht eines Patienten mit akuter Dyspnoe bei fortgeschrittenem Bronchialkarzinom wurde an Studenten verteilt mit der Bitte, diagnostische und therapeutische Optionen nach einem Rankingsystem anzugeben. ERGEBNISSE: 633 Medizinstudenten erhielten einen Fallbericht, dieser wurde von 423 vollständig ausgefüllt. Die häufigste diagnostische Maßnahme war die Messung der Sauerstoffsättigung mittels Pulsoxymeter (n = 388), gefolgt von Auskultation (n = 339). Die häufigste Behandlungsoption für Studenten war die Verabreichung von Sauerstoff (n = 393). Immerhin 138 Studenten schlugen die Verabreichung von Opioiden vor. SCHLUSSFOLGERUNGEN: Obwohl die Studenten über wenig praktische Erfahrung verfügten, schlugen 32,6% eine Behandlung mit Opioiden vor.

Summary

BACKGROUND: Dyspnea is common in advanced cancer patients with opioids as first line treatment. OBJECTIVES: To evaluate the level of knowledge about diagnosis and treatment of dyspnea in palliative care patients among 4th year students. METHODS: A case report was distributed to the students describing acute dyspnea in a lung cancer patient. Students were asked to rank their diagnosis and treatment options by importance. RESULTS: 633 medical students in their 4th year attended a seminar about palliative care. Of these, 423 (77%) completed the case report. The most frequent diagnostic option was measuring patient's oxygen saturation (n = 388), followed by auscultation (n = 339). As treatment options, students chose the delivery of oxygen (n = 393) as most important. The application of opioids was suggested by a total of 138 students. CONCLUSION: Although students did not have practical skills in treating advanced cancer patients with acute dyspnea, 32.6% would suggest an opioid as treatment option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bruera E, Schmitz B, Pither J, et al. The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage, 19: 357–362, 2000

    Article  PubMed  CAS  Google Scholar 

  • Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest, 89: 234–236, 1986

    Article  PubMed  CAS  Google Scholar 

  • Curtis EB, Krech R, Walsh TD. Common symptoms in patients with advanced cancer. J Palliat Care, 7: 25–29, 1991

    PubMed  CAS  Google Scholar 

  • Dudgeon DJ, Kristjanson L, Sloan JA, et al. Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage, 21: 95–102, 2001

    Article  PubMed  CAS  Google Scholar 

  • Higginson I, McCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med, 82: 264–267, 1989

    PubMed  CAS  Google Scholar 

  • Conill C, Verger E, Henriquez I, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage, 14: 328–331, 1997

    Article  PubMed  CAS  Google Scholar 

  • Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage, 20: 104–112, 2000

    Article  PubMed  CAS  Google Scholar 

  • Simon ST, Bausewein C. Management of refractory breathlessness in patients with advanced cancer. Wien Med Wochenschr, 159: 591–598, 2009

    Article  PubMed  Google Scholar 

  • Viola R, Kiteley C, Lloyd NS, et al. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer, 16: 329–337, 2008

    Article  PubMed  Google Scholar 

  • Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57: 939–944, 2002

    Article  PubMed  Google Scholar 

  • Chan KSMTDTA. Palliative medicine in malignant respiratory diseases. In: Doyle D GHNCKC (ed) Oxford textbook of palliative medicine. Third edition. Oxford University Press, 2005.

  • Kin-Sang Chan DMWTMMKS&ABT. Palliative medicine in malignant respiratory diseases. In: Geoffrey Hanks NICNACMFSKaRKP (ed) Oxford textbook of palliative medicine. Fourth edition. Oxford University Press, 2009.

  • Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med, 10: 299–305, 1996

    Article  PubMed  CAS  Google Scholar 

  • Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev, 2008(2): 16, 2008

    Google Scholar 

  • Kemp C. Palliative care for respiratory problems in terminal illness. Am J Hosp Palliat Care, 14: 26–30, 1997

    Article  PubMed  CAS  Google Scholar 

  • Pan CX, Morrison RS, Ness J, et al. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage, 20: 374–387, 2000

    Article  PubMed  CAS  Google Scholar 

  • Thomas JR, Von Gunten CF. Clinical management of dyspnoea. Lancet Oncol, 3: 223–228, 2002

    Article  PubMed  CAS  Google Scholar 

  • Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet, 342(8862): 13–14, 1993

    Article  PubMed  CAS  Google Scholar 

  • Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med, 119: 906–907, 1993

    PubMed  CAS  Google Scholar 

  • Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010(1): 20, 2010

    Google Scholar 

  • Thomas JR, Von Gunten CF. Management of dyspnea. J Support Oncol, 1: 23–32, 2003

    PubMed  Google Scholar 

  • Davis CL. ABC of palliative care. Breathlessness, cough, and other respiratory problems. BMJ, 315(7113): 931–934, 1997

    Article  PubMed  CAS  Google Scholar 

  • Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care – Part III: dyspnea and delirium. J Palliat Med, 9: 422–436, 2006

    Article  PubMed  Google Scholar 

  • Batchelor TT, Taylor LP, Thaler HT, et al. Steroid myopathy in cancer patients. Neurology, 48: 1234–1238, 1997

    PubMed  CAS  Google Scholar 

  • Croxton TL, Weinmann GG, Senior RM, et al. Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med, 167: 1142–1149, 2003

    Article  PubMed  Google Scholar 

  • Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med, 89: 291–296, 1995

    Article  PubMed  CAS  Google Scholar 

  • Kauser F, LeGrand SB. Theophylline for unexplained dyspnea in palliative medicine: a case report. J Palliat Med, 11: 510–513, 2008

    Article  PubMed  Google Scholar 

  • Cachia E, Ahmedzai SH. Breathlessness in cancer patients. Eur J Cancer, 44: 1116–1123, 2008

    Article  PubMed  Google Scholar 

  • Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage, 21: 373–379, 2001

    Article  PubMed  CAS  Google Scholar 

  • Bruera E, Schoeller T, MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage, 7: 365–368, 1992

    Article  PubMed  CAS  Google Scholar 

  • Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database Syst Rev, 2008(3): 16, 2008

    Google Scholar 

  • Uronis HE, Abernethy AP. Oxygen for relief of dyspnea: what is the evidence? Curr Opin Support Palliat Care, 2: 89–94, 2008

    Article  PubMed  Google Scholar 

  • Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage, 5: 341–344, 1990

    Article  PubMed  CAS  Google Scholar 

  • Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med, 159: 321–340, 1999

    Google Scholar 

  • Ben Aharon I, Gafter-Gvili A, Paul M, et al. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol, 26: 2396–2404, 2008

    Article  PubMed  Google Scholar 

  • Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage, 39: 680–690, 2010

    Article  PubMed  Google Scholar 

  • Boyd KJ, Kelly M. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliat Med, 11: 277–281, 1997

    Article  PubMed  CAS  Google Scholar 

  • Cohen MH, Anderson AJ, Krasnow SH, et al. Continuous intravenous infusion of morphine for severe dyspnea. South Med J, 84: 229–234, 1991

    Article  PubMed  CAS  Google Scholar 

  • Ventafridda V, Ripamonti C, De Conno F, et al. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care, 6: 7–11, 1990

    PubMed  CAS  Google Scholar 

  • Zeppetella G. Nebulized morphine in the palliation of dyspnoea. Palliat Med, 11: 267–275, 1997

    Article  PubMed  CAS  Google Scholar 

  • Booth S, Kelly MJ, Cox NP, et al. Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med, 153: 1515–1518, 1996

    PubMed  CAS  Google Scholar 

  • Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med, 11: 204–216, 2008

    Article  PubMed  Google Scholar 

  • Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327(7414): 523–528, 2003

    Article  PubMed  CAS  Google Scholar 

  • Borasio GD, Weltermann B, Voltz R, et al. Attitudes towards patient care at the end of life. A survey of directors of neurological departments. Nervenarzt, 75: 1187–1193, 2004

    Article  PubMed  CAS  Google Scholar 

  • Bendiane MK, Peretti-Watel P, Pegliasco H, et al. Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians' attitudes. J Opioid Manag, 1: 25–30, 2005

    PubMed  Google Scholar 

  • Navigante AH, Cerchietti LC, Castro MA, et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage, 31: 38–47, 2006

    Article  PubMed  CAS  Google Scholar 

  • Navigante AH, Castro MA, Cerchietti LC. Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated. J Pain Symptom Manage, 39: 820–830, 2010

    Article  PubMed  CAS  Google Scholar 

  • Rigg JR. Ventilatory effects and plasma concentration of morphine in man. Br J Anaesth, 50: 759–765, 1978

    Article  PubMed  CAS  Google Scholar 

  • LeGrand SB, Khawam EA, Walsh D, Rivera NI. Opioids, respiratory function, and dyspnea. Am J Hosp Palliat Care, 20: 57–61, 2003

    Article  PubMed  Google Scholar 

  • Walsh TD. Opiates and respiratory function in advanced cancer. Recent Results Cancer Res, 89: 115–117, 1984

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gudrun Pohl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pohl, G., Marosi, C., Dieckmann, K. et al. Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna. Wien Med Wochenschr 162, 18–28 (2012). https://doi.org/10.1007/s10354-011-0046-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-011-0046-z

Schlüsselwörter

Keywords

Navigation